Described herein are pharmaceutical packaging systems which prevent oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medication, these devices which include a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen an